INAB In8Bio Inc

Price (delayed)

$1.54

Market cap

$15.16M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.61

Enterprise value

-$4.42M

?
Relative Growth: Rel. Growth: 23
Relative Strength: Rel. Strength: 14
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 9
Highlights
In8Bio's quick ratio has soared by 153% YoY and by 19% from the previous quarter
The EPS has soared by 80% YoY and by 41% QoQ
In8Bio's equity has soared by 64% YoY but it has decreased by 17% from the previous quarter

Key stats

What are the main financial stats of INAB

INAB stock price

How has the In8Bio stock price performed over time
Intraday
0%
1 week
-14.44%
1 month
-4.35%
1 year
-58.15%
YTD
-34.19%
QTD
4.05%

Financial performance

How have In8Bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$19.47M
Net income
-$18.98M
Gross margin
N/A
Net margin
N/A
INAB's net income is up by 31% YoY and by 2.4% from the previous quarter
INAB's operating income is up by 30% year-on-year

Price vs fundamentals

How does INAB's price correlate with its fundamentals

Growth

What is In8Bio's growth rate over time

Valuation

What is In8Bio stock price valuation
P/E
N/A
P/B
0.67
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has soared by 80% YoY and by 41% QoQ
In8Bio's equity has soared by 64% YoY but it has decreased by 17% from the previous quarter
INAB's P/B is 61% below its 5-year quarterly average of 1.7 but 34% above its last 4 quarters average of 0.5

Efficiency

How efficient is In8Bio business performance
The return on equity has surged by 56% year-on-year and by 13% since the previous quarter
The ROA has increased by 42% YoY and by 9% from the previous quarter
In8Bio's ROIC has decreased by 39% YoY and by 17% from the previous quarter

Dividends

What is INAB's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for INAB.

Financial health

How did In8Bio financials performed over time
In8Bio's quick ratio has soared by 153% YoY and by 19% from the previous quarter
The company's current ratio has surged by 144% YoY and by 19% QoQ
In8Bio's debt is 90% less than its equity
In8Bio's debt to equity has shrunk by 68% YoY
In8Bio's equity has soared by 64% YoY but it has decreased by 17% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.